2 completed, 1 unknown. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
Follow MetaboGen AB: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of F. Prausnitzii on Glycemic Control F. prausnitzii and D. piger, Placebo - Pre Diabetes, Impaired Glucose Tolerance | Not applicable | Unknown | MetaboGen AB | 176 | 2021-08-16 | 2021-09-02 |
| Tolerability and Risk of Adverse Events With a Probiotic Supplement Placebo, High dose F. prausnitzii and D. piger, Low dose F. prausnitzii and D. piger - Healthy Individuals | Not applicable | Completed | Sahlgrenska University Hospital | 50 | 2018-10-10 | 2020-02-25 |
| The Microbiome Composition in Women With Recurring Intrahepatic Cholestasis of Pregnancy (ICP) Exploratory - Intrahepatic Cholestasis of Pregnancy | Completed | MetaboGen AB | 105 | 2017-02-14 | 2021-12-09 |
Glucose Intolerance (1) · Intrahepatic Cholestasis of Pregnancy (1) · Non-alcoholic Fatty Liver Disease (1)
Sweden (3)
Hanns-Ulrich Marschall (1) · Helena Strevens, MD, PhD (1) · Mattias Lorenzon, MD, PhD (1)